Rigel Pharmaceuticals Inc banner

Rigel Pharmaceuticals Inc
NASDAQ:RIGL

Watchlist Manager
Rigel Pharmaceuticals Inc Logo
Rigel Pharmaceuticals Inc
NASDAQ:RIGL
Watchlist
Price: 32.43 USD 2.08% Market Closed
Market Cap: $599m

During the last 3 months Rigel Pharmaceuticals Inc insiders have not bought any shares, and sold 145.4k USD worth of shares. The stock price has dropped by 11% over this period (open performance analysis).

The last transaction was made on Feb 20, 2026 by Moos Walter H , who sold 145.4k USD worth of RIGL shares.

Last Transactions:
Moos Walter H
$-145.4k
Santos David A
$-39.4k
Furey Raymond J.
$-29.4k
Rodriguez Raul R
$-96.5k
Schorno Dean L
$-38k
Schorno Dean L
$-42.6k
Furey Raymond J.
$-30.3k
Rodriguez Raul R
$-103.6k
Santos David A
$-44.5k
Santos David A
$-1k
Rodriguez Raul R
$-3.5k
Schorno Dean L
$-801.4
Santos David A
$-632.8
Rodriguez Raul R
$-2.5k
Schorno Dean L
$-632.6
Rodriguez Raul R
$-3.6k
Dummer Wolfgang
$-894.8
Santos David A
$-894.8
Schorno Dean L
$-894.8
Rodriguez Raul R
$+68.8k
Schorno Dean L
$+10k
Cabatuan Nelson
$-3.1k
Duliege Anne-Marie
$-40.4k
Mayer Eldon C. Iii
$+16.1k
Mayer Eldon C. Iii
$+16.4k
Duliege Anne-Marie
$-5.8k
Mayer Eldon C. Iii
$+28.2k
Rodriguez Raul R
$+30k
Duliege Anne-Marie
$-1.4k
Duliege Anne-Marie
$-2.1k
Maynard Ryan D
$-39k
Duliege Anne-Marie
$-1.3k
View All Transactions

During the last 3 months Rigel Pharmaceuticals Inc insiders have not bought any shares, and sold 145.4k USD worth of shares. The stock price has dropped by 11% over this period (open performance analysis).

The last transaction was made on Feb 20, 2026 by Moos Walter H , who sold 145.4k USD worth of RIGL shares.

Sold
0-3
months
145.4k USD
1
3-6
months
0 USD
0
6-9
months
0 USD
0
9-12
months
0 USD
0
Bought
0-3
months
0
0 USD
3-6
months
No Insider Transactions
0
0 USD
6-9
months
No Insider Transactions
0
0 USD
9-12
months
No Insider Transactions
0
0 USD

Rigel Pharmaceuticals Inc
Insider Trading Chart

Rigel Pharmaceuticals Inc
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

Rigel Pharmaceuticals Inc
Last Insider Transactions

Global
Insiders Monitor

Rigel Pharmaceuticals Inc
Glance View

Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. The company is headquartered in South San Francisco, California and currently employs 165 full-time employees. The company went IPO on 2000-11-29. The firm is engaged in discovering, developing and providing small molecule drugs that improve the lives of patients with hematologic disorders, cancer and rare immune diseases. The firm's research focuses on signaling pathways that are critical to disease mechanisms. The firm's product, TAVALISSE (fostamatinib disodium hexahydrate) tablets, the spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia (ITP). The Company’s product is also commercially available in Europe, the United Kingdom (UK) (TAVLESSE) and Canada (TAVALISSE) for the treatment of chronic ITP in adult patients. Its clinical programs include its interleukin receptor-associated kinase (IRAK) inhibitor program and a receptor-interacting serine/threonine-protein kinase (RIPK1) inhibitor program in clinical development with partner Eli Lilly and Company (Lilly).

RIGL Intrinsic Value
LOCKED
Unlock

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett